Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.

Click here to find out that this 8,788% cryptocurrency is.

Wilfred can Zuilen net worth and biography

Wilfred can Zuilen Biography and Net Worth

Insider of Zimmer Biomet

Mr. van Zuilen will be responsible for the marketing, sales and distribution of products, services and solutions in the EMEA region. Prior to joining Zimmer Biomet, Mr. van Zuilen served as Regional Vice President, North Western Europe (United Kingdom, Ireland, Nordics and Benelux) at Medtronic. Prior to that, he led Medtronic's Restorative Therapies Group of businesses for EMEA and has also held regional leadership positions with Covidien, Novartis and Edwards Lifesciences.

Mr. van Zuilen holds a bachelor's degree in Business Economics from Erasmus University in Rotterdam.

What is Wilfred can Zuilen's net worth?: The estimated net worth of Wilfred can Zuilen is at least $271,420.80 as of July 5th, 2022. Mr. can Zuilen owns 2,240 shares of Zimmer Biomet stock worth more than $271,421 as of April 25th. This net worth evaluation does not reflect any other investments that Mr. can Zuilen may own. Learn More about Wilfred can Zuilen's net worth.
How do I contact Wilfred can Zuilen?: The corporate mailing address for Mr. can Zuilen and other Zimmer Biomet executives is 345 EAST MAIN STREET, WARSAW IN, 46580. Zimmer Biomet can also be reached via phone at (574) 267-6131 and via email at [email protected]. Learn More on Wilfred can Zuilen's contact information.
Has Wilfred can Zuilen been buying or selling shares of Zimmer Biomet?: Wilfred can Zuilen has not been actively trading shares of Zimmer Biomet over the course of the past ninety days. Most recently, Zuilen Wilfred Van sold 531 shares of the business's stock in a transaction on Tuesday, July 5th. The shares were sold at an average price of $105.22, for a transaction totalling $55,871.82. Following the completion of the sale, the insider now directly owns 2,240 shares of the company's stock, valued at $235,692.80. Learn More on Wilfred can Zuilen's trading history.
Who are Zimmer Biomet's active insiders?: Zimmer Biomet's insider roster includes Betsy Bernard (Director), Wilfred can Zuilen (Insider), Robert Hagemann (Director), Bryan Hanson (CEO), Arthur Higgins (Director), Sreelakshmi Kolli (Director), Michael Michelson (Director), Chad Phipps (VP), and Sang Yi (Insider). Learn More on Zimmer Biomet's active insiders.
Are insiders buying or selling shares of Zimmer Biomet?: During the last year, Zimmer Biomet insiders bought shares 4 times. They purchased a total of 5,300 shares worth more than $619,090.00. During the last year, insiders at the medical equipment provider sold shares 1 times. They sold a total of 26,156 shares worth more than $3,364,184.72. The most recent insider tranaction occured on February, 22nd when VP Chad F Phipps sold 26,156 shares worth more than $3,364,184.72. Insiders at Zimmer Biomet own 1.0% of the company. Learn More about insider trades at Zimmer Biomet.
Information on this page was last updated on 2/22/2024.

Wilfred can Zuilen Insider Trading History at Zimmer Biomet

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
7/5/2022	Sell	531	$105.22	$55,871.82	2,240

Wilfred can Zuilen Buying and Selling Activity at Zimmer Biomet

Zimmer Biomet Company Overview

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Today's Range

Now: $119.75

$118.77

$121.35

50 Day Range

MA: $126.18

$119.41

$132.61

2 Week Range

Now: $119.75

$102.00

$149.25

Volume

1,078,771 shs

Average Volume

1,449,646 shs

Market Capitalization

$24.60 billion

P/E Ratio

24.49

Dividend Yield

0.79%

Beta

1.01